OP 100 (Lynparza 100 mg)
Generic Name: olaparib
Pill with imprint OP 100 is Yellow, Elliptical / Oval and has been identified as Lynparza 100 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Lynparza is used in the treatment of ovarian cancer; prostate cancer; breast cancer, metastatic; pancreatic cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OP 100
Lynparza
- Generic Name
- olaparib
- Imprint
- OP 100
- Strength
- 100 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Parp inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-0668
- Inactive Ingredients
-
hypromelloses,
titanium dioxide,
polyethylene glycol 400,
ferric oxide yellow,
water,
ferrosoferric oxide,
copovidone,
silicon dioxide,
mannitol,
sodium stearyl fumarate
Note: Inactive ingredients may vary.
Related Images for "OP 100"
More about Lynparza (olaparib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: PARP inhibitors
- FDA Approval History
Consumer resources
- Patient Information
- Lynparza (Advanced Reading)
- Lynparza (Olaparib Capsules)
- Lynparza (Olaparib Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.